National Taiwan Normal University
Taipei, 106, Taiwan
NCT Number: NCT07737938
With the widespread use of digital devices and prolonged screen exposure, digital eye strain (DES), also known as computer vision syndrome, has become a global public health concern. Emerging evidence suggests that the gut-eye axis may play an important role in ocular health, as gut microbiota imbalance is associated with systemic inflammation and oxidative stress. Specific probiotics may help alleviate eye discomfort through modulation of immune responses and enhancement of antioxidant defense mechanisms. This randomized, double-blind, placebo-controlled study aims to evaluate the efficacy of supplementation with specific probiotics, Bifidobacterium longum BL531 and Lactobacillus reuteri LR1349, in improving digital eye strain symptoms in adults.
Trial opening soon.
Get Notified20 year–65 year
All sexes
Interventional
Not applicable
Taipei, 106, Taiwan
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Maltodextrin
1×10^10 cfu/day
2.5×10^10 cfu/day
1×10^10 cfu/day
2.5×10^10 cfu/day
Time frame: Baseline, Week 6, Week 12
The CVS-Q is a questionnaire used to assess digital eye strain associated with prolonged digital screen use. It includes 16 symptoms related to screen exposure. Total scores are classified as 0-5 (none/minimal), 6-12 (mild), 13-18 (moderate), and ≥19 (severe), with scores ≥6 indicating clinically significant digital eye strain.
Time frame: Baseline, Week 6, Week 12
The Ocular Surface Disease Index (OSDI) is a 12-item questionnaire used to assess the severity of dry eye symptoms and their impact on vision-related function and daily activities. Total scores range from 0 to 100, with higher scores indicating greater symptom severity.
Time frame: Baseline and Week 12
A comprehensive ophthalmic examination will be performed, including uncorrected distance and near visual acuity, automated refraction, presbyopia assessment, distance and near vision correction, intraocular pressure measurement, and external eye photography for conjunctival hyperemia assessment.
Time frame: Baseline and Week 12
Pupillary response testing will be performed using the Oculus Pentacam HR or an equivalent device to evaluate pupil size and response time under light and dark conditions. This assessment provides information on the visual system's adaptation to changes in illumination.
Time frame: Baseline and Week 12
Tear meniscus height will be measured using the OS1000 Corneal Topographer (SBM sistemi, Italy) or an equivalent device as an indicator of tear secretion.
Time frame: Baseline and Week 12
Non-invasive tear break-up time (NIBUT) will be measured using the OS1000 Corneal Topographer (SBM sistemi, Italy) or an equivalent device to evaluate tear film stability. A shorter NIBUT is commonly associated with dry eye symptoms and digital eye strain.
Time frame: Baseline and Week 12
Corneal tomography and topography analysis will be performed using the Oculus Pentacam HR or an equivalent device to evaluate corneal morphology, curvature, thickness, and regularity.
Time frame: Baseline and Week 12
Accommodative function will be assessed using the ARK-1s Auto Ref-Keratometer (NIDEK, Japan) or an equivalent device to evaluate the eye's focusing ability and quantify accommodative responses associated with ciliary muscle contraction and relaxation.
Time frame: Baseline and Week 12
The Worth Four Dot Test will be used to assess binocular vision and fusion ability by evaluating responses to red and green visual targets, including the presence of suppression or diplopia.
Contact information is provided by the study sponsor or research team.
Chia-Chia Lee
CONTACT
+886-07-6955680 Ext. 2921
Han-Yin Hsu
CONTACT
+886-07-6955680 Ext. 2923
Synbio Tech Inc.
Industry
The Application of Lactic Acid Bacteria on Reducing Blue Light-Induced Eye Fatigue in Middle-Aged Adults
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07707908
Computer Vision Syndrome, Digital Eye Strain (DES)
Banhā, Benha, Egypt
View Trial DetailsNCT07706231
Asthenopia, Computer Vision Syndrome
Guangzhou, Guangdong, China
View Trial DetailsNCT07691671
Asthenopia, Eye Diseases
View Trial DetailsNCT07571655
Asthenopia, Cervical Myofascial Pain Syndrome
Rawalpindi, Punjab Province, Pakistan
View Trial Details